Skip to main content
Premium Trial:

Request an Annual Quote

Are You Sure?

In Nature last week, Massachusetts General Hospital's Daniel MacArthur wrote an opinion article saying false positives are a given in genomic research. Researchers and journals are eager to publish interesting results, he said, however, "two processes conspire to delude ambitious genomicists" — one being the size of the genome, which causes unusual events to occur frequently and the second being the nuances of high-throughput technology, which can lead to errors that can be misinterpreted.

At The Mermaid's Tale, Penn State's Ann Buchanan says the fact that journals are issuing lots of retractions is evidence that "often results are simply wrong, either for technical reasons or because statistical tests were inappropriate, wrongly done, incorrectly interpreted or poorly understood." And although peer review catches some of these mistakes, reviewers and journal editors aren't getting all of them, she says. Added to that is the pressure to publish, which can sometimes make even the most exacting researcher overlook what may be red flags. What's needed in research, Buchanan says, is a "healthy skepticism."

"You don't have to work with online genomic databases very long before it becomes obvious — at least to the healthy skeptic — that you have to check and recheck the data," she adds.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.